Skip to main content

Advertisement

Log in

Cigarette smoking and pulmonary diffusion defects in rheumatoid arthritis

  • ORIGINAL ARTICLE
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The pathogenesis of lung disease in rheumatoid arthritis (RA) has still to be defined. Risk factors associated with lung involvement in RA were investigated by means of pulmonary function studies in 40 RA patients without apparent lung disease. A decreased carbon monoxide (CO) diffusion capacity indicative of interstitial lung disease (ILD) was the main pulmonary function defect found in the first 20 patients. The occurrence was associated with current cigarette smoking. This association was confirmed in a case control study performed subsequently. These data suggest that ILD in RA is stimulated by smoking and provide an additional argument that modification of smoking behaviour in RA patients might lead to less severe complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 15 January 1998 / Accepted: 12 March 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Westedt, M., Hazes, J., Breedveld, F. et al. Cigarette smoking and pulmonary diffusion defects in rheumatoid arthritis. Rheumatology International 18, 1–4 (1998). https://doi.org/10.1007/s002960050045

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002960050045

Navigation